alpha-aminopyridine has been researched along with Angiogenesis, Pathologic in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 13 (92.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, JW; Kim, SJ; Kim, YA; Kim, YK; Lee, HY; Lee, SH; Yeo, CD | 1 |
Chen, B; Kraus, D; Palasuberniam, P | 1 |
Amato, LB; Baldassarre, M; Bridgeman, VL; Columbaro, M; Cossarizza, A; De Luise, M; Feichtinger, RG; Foriel, S; Gasparre, G; Gibellini, L; Girolimetti, G; Grifoni, D; Iommarini, L; Kofler, B; Kurelac, I; Leone, G; Malanchi, I; Ombrato, L; Porcelli, AM; Ragazzi, M; Sollazzo, M; Umesh Ganesh, N; Vatrinet, R; Vidali, S; Vidone, M | 1 |
Fan, Y; Huang, Z; Li, Y; Qin, Z; Shi, Y; Wang, T; Xiang, R; Yang, S; Zhao, B; Zheng, J; Zhou, W | 1 |
Abe, T; Adachi, Y; Funahashi, Y; Kato, Y; Kawano, S; Matsui, J; Matsushima, T; Nakagawa, T; Nakazawa, Y; Semba, T; Tsuruoka, A; Yokoi, A | 1 |
Balsas, P; Campo, E; Casserras, T; Colomer, D; Giné, E; Kalko, SG; López-Guillermo, A; Matas-Céspedes, A; Pérez-Galán, P; Rodriguez, V; Rosich, L; Roué, G; Vidal-Crespo, A; Villamor, N | 1 |
Ali-Fehmi, R; Armaiz-Pena, GN; Coleman, RL; Dalton, HJ; Dorniak, PL; Hansen, JM; Hu, W; Huang, J; Ivan, C; Previs, RA; Rupaimoole, R; Sood, AK; Thanapprapasr, D | 1 |
Ahn, YM; Booth, RJ; Caldwell, TM; Chun, L; Clare, M; Ensinger, CL; Flynn, DL; Hood, MM; Kaufman, MD; Leary, CB; Lu, WP; Patt, TW; Patt, WC; Rutkoski, TJ; Samarakoon, T; Smith, BD; Stewart, LJ; Telikepalli, H; Turner, BA; Vogeti, L; Vogeti, S; Wise, SC; Yates, KM | 1 |
Miele, L; Morello, S; Pinto, A; Porta, A; Sorrentino, C | 1 |
Aguiar, RCT; Bhatnagar, H; Holder, KN; Kim, SW; Lin, AP; Moritz, AW; Suhasini, AN; Wang, L | 1 |
Banskota, S; Gautam, J; Gurung, P; Jeong, BS; Kim, JA; Kim, SJ; Nam, TG; Park, MH; Regmi, SC | 1 |
Fiedler, W; Schultze, A | 1 |
Donev, IS; Kita, K; Li, Q; Matsumoto, K; Nakagawa, T; Nakamura, T; Nishioka, Y; Shimizu, E; Sone, S; Takeuchi, S; Uenaka, T; Wang, W; Yamada, T; Yano, S | 1 |
Cho, EH; Chung, SG; Jeong, EJ; Joo, JH; Kang, DW; Kim, YJ; Kwon, HS; Lee, MS; Lee, SH; Park, SK; Song, HS; Yi, EY | 1 |
1 review(s) available for alpha-aminopyridine and Angiogenesis, Pathologic
Article | Year |
---|---|
Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hydroxamic Acids; Indoles; Male; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Pancreatic Neoplasms; Prostatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides | 2011 |
13 other study(ies) available for alpha-aminopyridine and Angiogenesis, Pathologic
Article | Year |
---|---|
Roflumilast treatment inhibits lung carcinogenesis in benzo(a)pyrene-induced murine lung cancer model.
Topics: Aminopyridines; Animals; Benzamides; Benzo(a)pyrene; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Mice; Neovascularization, Pathologic | 2017 |
Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy.
Topics: Aminopyridines; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Endothelial Cells; Humans; Imidazoles; Mice; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Neoplasms; Neovascularization, Pathologic; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Photochemotherapy; Porphyrins; Protein Kinase Inhibitors; Quinolines; Signal Transduction; Thiazoles; Verteporfin; Xenograft Model Antitumor Assays | 2017 |
Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses.
Topics: Adenoma, Oxyphilic; Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drosophila; Electron Transport Complex I; Female; Gene Knockout Techniques; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Metformin; Mice; Mice, Knockout; Mice, Nude; NADH Dehydrogenase; Neovascularization, Pathologic; Pyrroles; Xenograft Model Antitumor Assays | 2019 |
Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis.
Topics: Aminopyridines; Anilides; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyridines; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Hepatocyte Growth Factor; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-met; Quinolines; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2014 |
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
Topics: Aminopyridines; Animals; Cell Adhesion; Cell Communication; Cell Line, Tumor; Cell Movement; Cell Survival; Chemokine CXCL12; Cluster Analysis; Dendritic Cells, Follicular; Disease Models, Animal; Extracellular Matrix; Gene Expression Profiling; Humans; Lymphoma, Follicular; Mice; Morpholines; Neovascularization, Pathologic; Phosphoinositide-3 Kinase Inhibitors; Receptors, CXCR4; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.
Topics: Aminopyridines; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hydroxamic Acids; Immunohistochemistry; Ki-67 Antigen; Mice, Nude; Mutation; Neovascularization, Pathologic; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.
Topics: Aminopyridines; Anilides; Animals; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Design; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Hepatocyte Growth Factor; Humans; Inhibitory Concentration 50; Melanoma, Experimental; Mice; Models, Molecular; Molecular Conformation; Monocytes; Neovascularization, Pathologic; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Receptor, TIE-2; Recombinant Proteins; Stromal Cells; Tumor Microenvironment; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2015 |
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
Topics: Aminopyridines; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Antigens, Ly; CD11b Antigen; Disease Models, Animal; Female; Flow Cytometry; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Neovascularization, Pathologic; Receptor, Adenosine A2B; Skin Neoplasms; T-Lymphocytes; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.
Topics: Aminopyridines; Animals; B-Lymphocytes; Benzamides; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Transgenic; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2016 |
BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.
Topics: Aminopyridines; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Aniline Compounds; Animals; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Gene Expression Regulation, Neoplastic; GTP-Binding Protein beta Subunits; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; NADPH Oxidases; Neovascularization, Pathologic; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Serotonin, 5-HT1; Serotonin; Signal Transduction; src-Family Kinases | 2016 |
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
Topics: Aminopyridines; Animals; Antibodies; Antibody Specificity; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Mice; Models, Biological; Mutation; Neovascularization, Pathologic; Piperazines; Proto-Oncogene Proteins c-met; Quinazolines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2012 |
Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
Topics: Aminopyridines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Biological Assay; Caspase 3; Caspases; Cell Line, Tumor; Cell Movement; Chick Embryo; Collagen; Cytochromes c; Drug Combinations; Laminin; Matrix Metalloproteinase 2; Mice; Neoplasms; Neovascularization, Pathologic; Piperazine; Piperazines; Proteoglycans | 2004 |